Therapeutic opportunities through modulation of the endocannabinoid system

Neuropharmacology

Volumn 48, Issue 8 SPEC. ISS., 2005, Pages 1068-1071

  Makriyannis, Alexandros ^a   Mechoulam, Raphael ^a   Piomelli, Daniele ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 4 [4 (1,1 DIMETHYLHEPTYL) 2,6 DIMETHOXYPHENYL] 6,6 DIMETHYLBICYCLO[3.1.1]HEPT 2 EN 2 YLMETHANOL; 4 [6 METHOXY 2 (4 METHOXYPHENYL) 3 BENZOFURANYLCARBONYL]BENZONITRILE; 7 HYDROXY 4' DIMETHYLHEPTYLCANNABIDIOL; AM 1172; AM 5171; ANANDAMIDE; BAY 387271; CANNABICHROMENE; CANNABICYCLOL; CANNABIDIOL; CANNABIDIOL DERIVATIVE; CANNABIGEROL; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; CANNABINOL; CANNABIS; DEXANABINOL; ENDOCANNABINOID; FATTY ACID AMIDASE INHIBITOR; HYDROLASE INHIBITOR; ICOSANOID; METHANANDAMIDE; N (4 HYDROXYPHENYL)ARACHIDONAMIDE; N OLEOYLETHANOLAMINE; O 2654; OMDM 8; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; RIMONABANT; SEROTONIN UPTAKE INHIBITOR; SLV 326; TETRAHYDROCANNABINOL; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANHEDONIA; ANTIINFLAMMATORY ACTIVITY; ANXIETY DISORDER; APPETITE DISORDER; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COUGHING; DRUG EFFICACY; DRUG INDUSTRY; DRUG RECEPTOR BINDING; HEROIN DEPENDENCE; HUMAN; HYPERALGESIA; HYPERTENSION; IMMUNOPATHOLOGY; INFERTILITY; MODULATION; NAUSEA; NEUROPATHIC PAIN; NEUROPROTECTION; NONHUMAN; OBESITY; PAIN; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STROKE; TOBACCO DEPENDENCE;

EID: 19444372967     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.03.012     Document Type: Note

References (0)